维克中国 Virbac China

DISCOVER VIRBAC

认识维克
维克集团 Virbac Group

维克集团 Virbac Group

这些创新的解决方案涵盖了主要物种和病理,维克日复一日地为塑造动物健康未来做出贡献。

With these innovative solutions covering the majority of animal species and diseases, Virbac contributes, day after day, to shape the future of animal health.

创始人 Founder

创始人 Founder

从1968年在尼斯的三室公寓里创建的实验室直到它成为了世界第七大实验室,我们回顾了一个伟大冒险的开端。

From a small biology research center established in 1968 in a three-room apartment in Nice to the world’s 7th largest laboratory, a look back at the beginnings of great human adventure.

价值 Values

价值 Values

培养创业精神,激励创新精神,展示我们的投入,培养以客户为导向的方法,注重以人为本,选择可持续性……

Nurture entrepreneurship, stimulate innovation, demonstrate our engagement, foster a customer-driven approach, pay attention to people and choose sustainability...

历史

1968

1970

1970

1973

1977

1982

1982

1985

1987

1988

1989

1991

1992

1992

1996

1998

1999

1999

2001

2001

2001

2006

2006

2008

2008

2010

2012

2015

2015

2016

2017

2017

2017

2018

2018

2018

2018

2019

2020

1968

PRD.png

建立SARL维克生物研究中心。

Pierre-Richard Dick, a French veterinarian, creates the SARL Virbac biological research center.

1970

1970.png

感谢在比利时、荷兰、卢森堡及德国的分销合作伙伴,维克开始在国际市场营销其产品。

We take our first steps internationally thanks to distribution partnerships in Benelux and the Federal Republic of Germany.

1970

COLLIER.png

维克为犬类研制了第一款除虫项圈,后来该产品成为公司旗舰产品之一。

We develop the first insecticide collar for dogs, which would later become one of our flagship products.

1973

batiment-construction.png

维克在尼斯附近的卡罗斯(Carros)建造了其未来总部的第一幢大楼,并迅速成立了生产,储存及装载部门。

We take a new step forward with the construction of the building of our future headquarters in Carros, near Nice, quickly adding a production and storage unit and a loading dock.

1977

rilexine.png

维克公司在法国推出了首个头孢菌素的兽医药物(用于犬、猫和牛),从而提供了不使用人用药头孢菌素情况下更好的选择。

We make available in France the first cephalosporin in veterinary medicine (for dogs, cats and cattle), thus providing an alternative to the cephalosporins derived from human pharmaceuticals.

1982

parvovirus.png

为了应对病毒性肠胃炎导致的大规模犬繁育问题,维克研发了第一种被批准用于犬的基于细小病毒的疫苗,从而成为了极少数有能力研发疫苗的实验室之一。

In response to the viral gastroenteritis epidemic decimating dog breeding, we create the first parvovirus-based vaccine approved for dogs, thus entering the very exclusive club of innovative vaccine-developing laboratories.

1982

filiale-allemagne.png

在收购了当地经销商VMG后,维克在德国开设了第一家子公司,这标志着维克在欧洲的进一步发展。​

The opening of our first subsidiary in Germany, following acquisition of local distributor VMG, marks the beginning of our deployment in Europe.

1985

bourse.png

维克——法国第二大动物健康实验室,在巴黎证券交易所的二级市场上市。

Number-two French animal health laboratory, we start to trade on the secondary market of the Paris stock exchange.

1987

allerderm.png

通过收购Allerderm Inc., 维克进入了美国,专注于兽医用皮肤科产品这个新的市场,并在几年后成为全球领导者。

With the acquisition of Allerderm Inc., we propel ourselves into the United States market. A specialist in the new veterinary dermatology market, we become the world leader a few years later.

1988

leucogen.png

维克用纯化的p45 FeLV-envelope逆转录病毒制成了第一种针对猫白血病的基因工程疫苗,它在猫白血病还没有治愈方法的时候为兽医提供了一种有效的治疗该疾病的方法。​

By designing the first genetically engineered vaccine against feline leukemia made from a purified p45 FeLV-envelope retrovirus, we provide veterinarians with an effective solution against a disease in cats for which there was no cure at the time.

1989

imperial-dog.png

维克收购了Imperial Dog,一个由皇家的创始人创建的犬、猫的食品生产商,现在成为了维克营养部门。

We open a new door with the acquisition of Imperial Dog, a dog and cat food manufacturer, founded by the creator of Royal Canin, now Virbac Nutrition.

1991

vaccin-renard.png

在欧洲,维克通过选择性突变的方法为狐狸提供了第一种口服狂犬病疫苗。

In Europe, we continue to move forward by offering the first oral anti-rabies vaccine for foxes, obtained by selective mutation.

1992

PRD-JD.png

维克公司创始人,兽医师皮埃尔-理查德-迪克(Pierre-Richard Dick)在一次中美洲海上航行中去世,享年55岁。当时的财务总监帕斯卡尔•博伊斯西(Pascal Boissy)接替他执掌公司。6个月后,公司采用了一个新的组织架构,由执行董事会和监事会组成,创始人的妻子珍妮-迪克(Jeanine Dick)成为董事长。

Our founder Pierre-Richard Dick, doctor of veterinary medicine, dies suddenly at the age of 55 while on a Central American sea voyage. Pascal Boissy, then financial director, succeeds him to head the company. Six months later, we adopt a new organizational structure made up of an executive board and a supervisory board, of which Jeanine Dick, wife of the founder, becomes chairwoman.

1992

1992.2.png

维克继续其国际扩张,在亚洲建立了第一个子公司(与日本进出口公司丸安合作)。

We push our international expansion further with the creation of our first subsidiary in Asia (a partnership with Maruyasu, a Japanese import-export company).

1996

fusion.png

​许多为了在法国领土上发展而创建的公司合并成一个子公司,维克法国,维克主品牌正式成立。

Numerous companies created to develop the company on French territory merge into a single subsidiary, Virbac France, formalizing the beginning of the Virbac umbrella brand.

1998

jelaime,jelevaccine.png

通过“爱宠物,就让它接种疫苗”的海报宣传活动,维克提高了法国公众对疫苗接种的认识。

Through its “I love my pet, I vaccinate it” poster campaign, we raise the general public’s awareness of vaccination in France.

1999

EM.png

Eric Marée, 48岁,HEC毕业生,美国康奈尔大学工商管理硕士,现任维克执行董事会主席。

Eric Marée, 48 years old, graduate of HEC and holder of an MBA from Cornell University in the United States, becomes chairman of the Virbac executive board.

1999

stlouis.png

由于收购了密苏里州圣路易斯的一家名为Agri-Nutrition的公司,维克新增了一系列牙科护理和清洁用品。

Thanks to the acquisition of Agri-Nutrition, a company based in St. Louis (Missouri), we acquire a range of dental care and hygiene products.

2001

virbagen-omega.png

维克为欧洲的犬、猫提供了第一种干扰素欧米茄。

We make available to European veterinarians the first interferon omega for dogs and cats.

2001

fondation2001.png

皮埃尔-理查德·迪克基金会(Pierre-Richard Dick Foundation)Pierre-Richard Dick Foundation成立于1993年,它在创始人去世后更改为维克企业基金会(Virbac Corporate Foundation)。该项目由他的儿子约翰-皮埃尔·迪克(Jean-Pierre Dick)担任主席,旨在提高公众意识,教育并告知(特别对于儿童),在城市中动物健康及人与动物相处的相关问题。​

The Pierre-Richard Dick Foundation, created in 1993 after our founder’s death, becomes the Virbac Corporate Foundation. It aims to raise public awareness, educate and inform, especially children, about issues related to the integration and well-being of animals in cities.

2001

JPdick.png

维克与其创始人的儿子约翰-皮埃尔·迪克(Jean-Pierre Dick)一起踏上了他的航海冒险之旅:通过参与史诗般的比赛,这位船长帮助提升了兽医行业,促进了动物健康。

We partner with Jean-Pierre Dick, son of our founder and doctor of veterinary medicine, on his sailing adventure: through his involvement in epic races, the skipper helps to enhance the veterinary profession, promote animal health and our values in the four corners of the world.

2006

MHDick.png

玛丽-海琳·迪克(Marie-Hélène Dick)作为一位专业兽医师和HEC的MBA毕业生被任命为维克监事会主席。

Marie-Hélène Dick, daughter of the founder, veterinary doctor and MBA graduate from HEC, is named chairwoman of Virbac’s supervisory board.

2006

inde.png

通过收购GlaxoSmithKline的动物健康部门Agrivet Farm Care,维克成为在此领域印度排名第一的企业。

We strengthen our presence with Indian veterinarians and farmers thanks to the acquisition of Agrivet Farm Care, the animal health branch of GlaxoSmithKline. A collaboration that allows us to become number 1 in this country.

2008

prod.png

维克现有7个工业园,分布于五大洲(法国、美国、墨西哥、巴西、澳大利亚、南非和越南)。

With 7 production units, we currently have an industrial park on five continents (France, United States, Mexico, Brazil, Australia, South Africa and Vietnam) to bring our health solutions ever closer to those who care for animals.

2008

suprelorin.png

维克为兽医师提供了第一种基于德舍瑞林的植入物,用于诱导雄性犬暂时性不育。

We share with veterinarians the first deslorelin-based implant, inducing a reversible neutering in male dogs.

2010

australie.png

维克与辉瑞签署了一项协议,获得一系列用于食用动物的产品(主要是驱虫药和牛羊疫苗)在澳大利亚的使用权。

We sign an agreement with Pfizer Inc. to acquire the Australian rights to a range of products for food producing animals, primarily parasiticides and vaccines for cattle and sheep.

2012

aqua.png

维克获得了Centrovet的多数股份,Centrovet是智利动物健康市场的领导者,是开发和生产用于冷水养殖农场(鲑鱼和鳟鱼)保护和处理的创新产品的专家。

Committed to the animal proteins of the future, we acquire a majority share of Centrovet, animal health market leader in Chile, expert in the development and production of innovative products for the protection and treatment of cold water aquaculture farms (salmon and trout).

2015

cochon.png

维克收购了Schweitzer生物技术公司,这是一家台湾公司,他们是细胞培养库开发方面的专家,而细胞培养库是生产用于猪和家禽的病毒疫苗的基础。这一收购正式确立了维克在东南亚建立生物研发的新结构,该地区被公认为全球最大的猪饲养和水产养殖(温水)市场。

We acquire Schweitzer Biotech Company, a Taiwanese company that is an expert in the development of cell culture banks serving as the basis for production of viral vaccines primarily for swine and poultry. This acquisition gives the impulse to the creation of a new biology R&D structure in Southeast Asia, a region recognized for the largest swine and aquaculture (warm water) markets on the planet.

2015

fondation.png

维克企业基金会意识到动物、人类和环境健康之间的相互联系带来的挑战,他们在津巴布韦的Gonarezhou公园发起了一项牛结核病和狂犬病筛查、控制和预防的项目。

The Virbac Corporate Foundation, aware of the challenges related to the interconnection between animal, human, and environmental health, initiates support for a screening, control, and prevention program for bovine tuberculosis and rabies in the Gonarezhou Park (Zimbabwe).

2016

argonavis.png

自2014年在Carros建造了VB8,这是一个致力于生产无菌注射剂的生产大楼,维克投入大量资金以确保其产品品质,并与VB8在墨西哥的另一家公司Argo Navis一起加强生产能力。

After the construction of VB8 in Carros in 2014, a production building dedicated to the manufacture of sterile injectables, Virbac continues to invest in quality and to strengthen its production capacities with Argo Navis, VB8’s alter ego in Mexico.

2017

petfood.png

2016年,维克为犬、猫推出了一系列宠物营养食品。其成分特别适合食肉动物的饮食需求。

After the physiological range in 2016, we provide dog and cat owners with a range of dietetic petfood. Their composition is particularly suited to the dietary needs of carnivores.

2017

voile.png

在掌管圣米歇尔-维克的时候,约翰-皮埃尔·迪克赢得了他的第四届雅克·瓦布里比赛(这是 Coffee Race 历史上的第一次)。这一胜利标志着这位帆船手生命中的一个转折点,也是他17年环游世界冒险生涯中最完美的结束。

At the helm of St. Michel-Virbac, Jean-Pierre Dick wins his fourth Jacques Vabre Race (a first in the history of the Coffee Race). This victory marks a turning point in the life of the sailor and the most fitting closure to his 17 years of adventures around the world, flying the colors of our company.

2017

SH.png

现年47岁的塞巴斯蒂安·休伦(Sebastien Huron)是兽医学博士、全球业务运营主管,自2012年起担任维克董事长,他接替了埃里克·马里(Eric Maree)。

Sébastien Huron, 47 years old, doctor of veterinary medicine, head of Global Business Operations, and member of the executive board since 2012, succeeds Éric Marée as chairman of Virbac.

2018

1.jpg2018年9月,维克庆祝了50周年纪念日。在为期两天的活动中,近3000名员工与创始人的家人一起参与。跨文化交流和参与动物健康服务的活动在友好的氛围中展开。

In September, we celebrate our 50th anniversary. Along with the family of our founder, nearly 3,000 connected employees share in a two-day event that unfolds in an atmosphere of warmth, intercultural sharing and engagement in the service of animal health.

2018

2.jpg维克的Smart Cap获得了欧洲药物制剂学奖,这是一种能安全提取液体产品的瓶盖(也获得了2019年ADF巴黎奖的认可)。

We win a Pharmapack Europe Award for the Smart Cap, a cap for safe extraction of liquid products (also recognized by the ADF Paris Awards in 2019). A great reward for our teams!

2018

3.jpg维克在其洁齿片系列中添加了了第一种针对口腔和消化系统引起口臭的牙科技术(Fr3sh)。

We include in our range of chews the first dental technology that fights both the oral and digestive causes of bad breath in dogs (Fr3sh).

2018

4.jpg

维克在几个亚洲地区(台湾、越南、菲律宾、韩国和泰国)生产一种食品补充剂,以提高仔猪出生10天内的存活率。

We make a food supplement available in several Asian countries (Taiwan, Vietnam, The Philippines, South Korea and Thailand) to improve the survival of piglets from birth to ten days old.

2019

2019.jpg针对猪环病毒的预防性解决方案,我们在几个亚洲国家及地区都取得了很好的成果,该病毒对农场会造成重大损失。维克团队开发的疫苗有助于限制这种疾病对世界最重要的猪产区的影响。

We make a jump in several Asian countries thanks to a preventive solution against porcine circovirus, a virus responsible for significant losses in farms. Developed by our teams with the genotype predominant in most regions of the world, this vaccine helps limit the impact of this disease in one of the world's most important swine production areas.

2020

2020.png我们向欧洲和北美兽医提供第一个可用于犬类乳腺瘤的肿瘤内注射产品,乳腺瘤是第二最常诊断的癌症也是最常见的皮肤癌。有了这种新型的注射方案,我们为犬皮肿瘤的治疗开辟了一条新路。

We offer to the European and North American veterinarians the first intratumoral injectable for canine mastocytomas, the second most frequently diagnosed cancer and the most common skin cancer. With this novel injectable solution, we are opening a new path in the treatment of canine skin tumors.

Legal notice
All medicines or products mentioned in this document can be not authorized or not marketed in all the countries including France. The product names stated in this document are subject to protection in particular in respect of trademarks. Virbac and/or its subsidiaries are the owners or have exclusive use of them.